Essilorluxottica (ESLOY)
113.37
+1.48
(+1.32%)
USD |
OTCM |
May 17, 16:00
Essilorluxottica Market Cap: 102.51B for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 17, 2024 | 102.51B |
| May 16, 2024 | 101.17B |
| May 15, 2024 | 102.30B |
| May 14, 2024 | 100.76B |
| May 13, 2024 | 100.14B |
| May 10, 2024 | 100.15B |
| May 09, 2024 | 100.33B |
| May 08, 2024 | 99.41B |
| May 07, 2024 | 100.06B |
| May 06, 2024 | 97.00B |
| May 03, 2024 | 97.00B |
| May 02, 2024 | 98.52B |
| May 01, 2024 | 98.15B |
| April 30, 2024 | 96.68B |
| April 29, 2024 | 97.53B |
| April 26, 2024 | 98.18B |
| April 25, 2024 | 98.08B |
| April 24, 2024 | 99.19B |
| April 23, 2024 | 99.27B |
| April 22, 2024 | 98.21B |
| April 19, 2024 | 98.23B |
| April 18, 2024 | 98.42B |
| April 17, 2024 | 96.75B |
| April 16, 2024 | 97.82B |
| April 15, 2024 | 97.07B |
| Date | Value |
|---|---|
| April 12, 2024 | 97.07B |
| April 11, 2024 | 99.07B |
| April 10, 2024 | 97.84B |
| April 09, 2024 | 100.08B |
| April 08, 2024 | 101.22B |
| April 05, 2024 | 99.80B |
| April 04, 2024 | 99.70B |
| April 03, 2024 | 102.79B |
| April 02, 2024 | 101.73B |
| April 01, 2024 | 102.62B |
| March 28, 2024 | 102.51B |
| March 27, 2024 | 103.41B |
| March 26, 2024 | 102.38B |
| March 25, 2024 | 102.75B |
| March 22, 2024 | 102.15B |
| March 21, 2024 | 103.18B |
| March 20, 2024 | 104.16B |
| March 19, 2024 | 102.46B |
| March 18, 2024 | 101.73B |
| March 15, 2024 | 103.31B |
| March 14, 2024 | 102.18B |
| March 13, 2024 | 102.05B |
| March 12, 2024 | 101.58B |
| March 11, 2024 | 101.40B |
| March 08, 2024 | 101.01B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
43.94B
Minimum
Apr 01 2020
104.16B
Maximum
Mar 20 2024
74.23B
Average
74.00B
Median
Apr 27 2021
Market Cap Benchmarks
| DBV Technologies SA | 112.23M |
| Cellectis SA | 215.14M |
| PHAXIAM Therapeutics SA (DELISTED) | -- |
| Genfit SA | 187.43M |
| Innate Pharma SA | 219.07M |
Market Cap Related Metrics
| PE Ratio | 41.14 |
| PS Ratio | 3.714 |
| PEG Ratio | 0.9415 |
| Price to Book Value | 2.425 |
| Price to Free Cash Flow | 28.35 |
| Price | 113.37 |
| Earnings Yield | 2.43% |
| PEGY Ratio | 0.8736 |
| Operating PE Ratio | 29.64 |
| Normalized PE Ratio | 41.14 |